Metabolic and hormonal aspects of polycystic ovary syndrome: the impact of diet (Q59607711)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Metabolic and hormonal aspects of polycystic ovary syndrome: the impact of diet (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

9 February 2020

main subject

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Annalouise O'Connor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

James Gibney

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

10 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json

Proceedings of the Nutrition Society

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

628-635

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json

Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Metformin has direct effects on human ovarian steroidogenesis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Peroxisome proliferator-activated receptors in reproductive tissues: from gametogenesis to parturition

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

n-3 fatty acids and gene expression

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

An retrospective audit of patients with polycystic ovary syndrome: the effects of a reduced glycaemic load diet

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

On the nature of semen quality and infertility

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

The 'carnivore connection'--evolutionary aspects of insulin resistance.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Distribution, interconversion, and dose response of n-3 fatty acids in humans

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Insulin signalling in human adipose tissue

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Fatty acids and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Effect of total parenteral nutrition with linoleic acid-rich emulsions on tissue omega 6 and omega 3 fatty acids in the rat

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Dietary fatty acid intakes and the risk of ovulatory infertility

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Free fatty acids increase androgen precursors in vivo.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Adipocytes as regulators of energy balance and glucose homeostasis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

A twenty-first century research agenda for polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

https://api.crossref.org/works/10.1017%2FS0029665110002016

1 reference

7 January 2021

Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Postprandial triglyceride response in patients with polycystic ovary syndrome: relationship with waist-to-hip ratio and insulin.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Increased adiposity in female rhesus monkeys exposed to androgen excess during early gestation.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Evidence for altered adipocyte function in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

https://api.crossref.org/works/10.1017%2FS0029665110002016

1 reference

7 January 2021

Relationships of generalized and regional adiposity to insulin sensitivity in men.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Quality of life and psychological well being in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Obesity and the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Mortality of women with polycystic ovary syndrome at long-term follow-up

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

The perils of portliness: causes and consequences of visceral adiposity

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Role of diet in the treatment of polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Inflammatory and endothelial markers in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Relation of nutrients and hormones in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Obesity and polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

The genetic basis of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Lilly lecture 1995. Glucose transport: pivotal step in insulin action

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Mechanisms behind lipolytic catecholamine resistance of subcutaneous fat cells in the polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Polycystic ovary syndrome and its developmental origins.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Abdominal adiposity and the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome--a pilot study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Contributions of androgen and estrogen to fetal programming of ovarian dysfunction.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Lipid metabolism in women

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

An arachidonic acid generation/export system involved in the regulation of cholesterol transport in mitochondria of steroidogenic cells

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization

1 reference

https://api.crossref.org/works/10.1017%2FS0029665110002016

7 January 2021

10.1017/S0029665110002016

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20696094%20AND%20SRC:MED&resulttype=core&format=json